{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:25:45Z","timestamp":1789104345239,"version":"build-2803163510"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T00:00:00Z","timestamp":1248739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The poor oral bioavailability of the opioid receptor antagonist naloxone (NA) when compared with naltrexone (NX) may be related to a greater interaction of naloxone with the efflux drug transporter P\u2010glycoprotein (P\u2010gp). We studied the involvement of P\u2010gp in the transepithelial transport of the two opioid receptor antagonists, using a validated human in vitro Caco\u20102 cell monolayer model. The bidirectional transport of NA and NX (1, 50 and 100\u2003\u03bc<jats:sc>m<\/jats:sc>) across the monolayers was investigated in the presence and absence of the specific P\u2010gp inhibitor GF120918 (4\u2003\u03bc<jats:sc>m<\/jats:sc>). NA and NX showed equal transport rates between the apical\u2010to\u2010basolateral (A\u2013B) and the basolateral\u2010to\u2010apical (B\u2013A) directions and neither the influx nor the efflux transport was affected by the P\u2010gp inhibitor (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05). In conclusion, NA and NX are not P\u2010gp substrates. The differential oral bioavailability of the two opioid antagonists is P\u2010gp independent.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2009.00724.x","type":"journal-article","created":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T07:10:01Z","timestamp":1248765001000},"page":"543-548","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["P\u2010glycoprotein is not involved in the differential oral potency of naloxone and naltrexone"],"prefix":"10.1111","volume":"23","author":[{"given":"Mouna","family":"Kanaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Daali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.36076\/ppj.2008\/11\/225","article-title":"Opioid antagonists, partial agonists, and agonists\/antagonists: the role of office\u2010based detoxification","volume":"11","author":"Helm S.","year":"2008","journal-title":"Pain Physician"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600601030"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-3565(25)29707-5","article-title":"Disposition of naloxone\u20107,8,3H in normal and narcotic\u2010dependent men","volume":"187","author":"Fishman J.","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_5_2","first-page":"273","article-title":"Review of naltrexone, a long\u2010acting opiate antagonist","volume":"3","author":"Crabtree B.L.","year":"1984","journal-title":"Clin. Pharm."},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00281.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198308040-00004"},{"key":"e_1_2_7_8_2","volume-title":"Pharmacological aspects of drug dependence. Towards an integrated neurobehavioral approach","author":"Kreek M.J.","year":"1996"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2004.00513.x"},{"key":"e_1_2_7_10_2","first-page":"15","article-title":"Bioequivalence, dose\u2010proportionality, and pharmacokinetics of naltrexone after oral administration","volume":"45","author":"Meyer M.C.","year":"1984","journal-title":"J. Clin. Psychiatry"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0090-9556(25)06161-6","article-title":"Metabolism and disposition of naltrexone in man after oral and intravenous administration","volume":"9","author":"Wall M.E.","year":"1981","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920008783571765"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016212804288"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600790604"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13914.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P\u2010glycoprotein assays in drug discovery","volume":"299","author":"Polli J.W.","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00607-4"},{"key":"e_1_2_7_18_2","unstructured":"Naloxone product information.http:\/\/www.documed.ch."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00052.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012102522787"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(97)00185-5"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)82357-2"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(95)00042-2"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198835030-00002"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-3565(25)29707-5","article-title":"Disposition of naloxone\u20107,8,3H in normal and narcotic\u2010dependent men","volume":"187","author":"Fishman J.","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00783-8"},{"key":"e_1_2_7_27_2","first-page":"426","article-title":"The impact of the addition of naloxone on the use and abuse of pentazocine","volume":"102","author":"Baum C.","year":"1987","journal-title":"Public Health Rep."},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-3-16"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.06.012"},{"key":"e_1_2_7_30_2","volume-title":"Isolation and Identification of Drugs in pharmaceuticals, body fluids, and post\u2010mortem material","author":"Clark\u2019s","year":"1986"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci0600814"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025032511040"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620903"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2009.00724.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2009.00724.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:30:22Z","timestamp":1739280622000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2009.00724.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,4]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1472-8206.2009.00724.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2009.00724.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,4]]},"assertion":[{"value":"2009-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}